Consumer Health in Australia

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,925	128 Pages	Euromonitor International	September, 2024	EP19208881

Best Price Guarantee
Price	from $2,925
Length	128 Pages
Publisher	Euromonitor International
Published Date	September, 2024
SKU	EP19208881

Consumer Health in Australia

The headlining trend for consumer health in Australia is the rising cost of living and inflation straining consumer budgets and overall spending. However, it is not just discretionary spending that is suffering, as some consumers are also being forced to reduce spending on essentials such as groceries to keep up with bills and debts. In general, consumer health is a resilient industry. Categories such as analgesics and cough, cold and allergy (hay fever) remedies are perceived as essential house...

Euromonitor International's Consumer Health in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.

Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Consumer Health market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Consumer Health in Australia
Euromonitor International
September 2024
List Of Contents And Tables
CONSUMER HEALTH IN AUSTRALIA
EXECUTIVE SUMMARY
Consumer health in 2024: The big picture
2024 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS: Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024; Table 2 Life Expectancy at Birth 2019-2024
MARKET DATA: Table 3 Sales of Consumer Health by Category: Value 2019-2024; Table 4 Sales of Consumer Health by Category: % Value Growth 2019-2024; Table 5 NBO Company Shares of Consumer Health: % Value 2020-2024; Table 6 LBN Brand Shares of Consumer Health: % Value 2021-2024; Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024; Table 8 Distribution of Consumer Health by Format: % Value 2019-2024; Table 9 Distribution of Consumer Health by Format and Category: % Value 2024; Table 10 Forecast Sales of Consumer Health by Category: Value 2024-2029; Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES: Summary 1 Research Sources
ANALGESICS IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Manufacturers and retailers respond to TGA decision to reduce acetaminophen pack sizes
Consumer demand for “natural” products drives NPD within adult acetaminophen and topical analgesics/anaesthetic
Marketing agenda within analgesics offers a wide scope for consumer engagement
PROSPECTS AND OPPORTUNITIES
Potential disruption to distribution landscape with proposed merger of Chemist Warehouse and Sigma Healthcare
Chronic conditions likely to further drive consumption of analgesics with stronger doses or target specific pain as population ages
Greater opportunities to leverage analgesics sales with Rx co-purchases
CATEGORY DATA: Table 12 Sales of Analgesics by Category: Value 2019-2024; Table 13 Sales of Analgesics by Category: % Value Growth 2019-2024; Table 14 NBO Company Shares of Analgesics: % Value 2020-2024; Table 15 LBN Brand Shares of Analgesics: % Value 2021-2024; Table 16 Forecast Sales of Analgesics by Category: Value 2024-2029; Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Normalising rates of influenza and RSV as life in Australia largely returns to pre-pandemic norms
Competitive landscape stabilises following withdrawal of cough suppressant pholcodine
Brands leverage winter sports sponsorship opportunities for new product launch and enhanced visibility during peak season
PROSPECTS AND OPPORTUNITIES
Australians monitoring health and medical developments overseas to influence public policy and consumer response
Seasonal and perennial allergic rhinitis to drive year-round sales in highly concentrated landscape of systemic antihistamines/allergy remedies
Proposed merger of Chemist Warehouse and Sigma Healthcare has the potential to significantly impact distribution landscape
CATEGORY DATA: Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2019-2024; Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2019-2024; Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2020-2024; Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2021-2024; Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2024-2029; Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2024-2029
DIGESTIVE REMEDIES IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Cost-of-living concerns translate into more exclusive spending on essentials, at the expense of adopting healthier behaviours
Gastroenteritis emerges as uncomfortable downside of exiting lockdown, as rotavirus and cryptosporidiosis levels surge across the country
Reduced competition within diarrhoeal remedies benefits leading players
PROSPECTS AND OPPORTUNITIES
Health and wellness to remain a priority for Australians through both choice and necessity
Further scrutiny of digestive remedies marketed online as health and wellness solutions to adolescents possible over the forecast period
Chemist Warehouse and Sigma Healthcare proposed merger anticipated to rewrite relationships with dominant branded players within category
CATEGORY DATA: Table 24 Sales of Digestive Remedies by Category: Value 2019-2024; Table 25 Sales of Digestive Remedies by Category: % Value Growth 2019-2024; Table 26 NBO Company Shares of Digestive Remedies: % Value 2020-2024; Table 27 LBN Brand Shares of Digestive Remedies: % Value 2021-2024; Table 28 Forecast Sales of Digestive Remedies by Category: Value 2024-2029; Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2024-2029
DERMATOLOGICALS IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Skin conditions impact the lives of a record number of survey respondents in Australia
Back-to-school a boon for head lice, driving sales of related healthcare products
Hair loss treatments benefits as men’s health conversations become increasingly mainstream
PROSPECTS AND OPPORTUNITIES
Growth of nappy (diaper) rash treatments likely to be curbed by demographic factors
Lobbying for a future national strategy towards eczema to address suboptimal treatment of the skin condition
Pharmacies to remain leading channel, with any shift in distribution status quo likely to be profound
CATEGORY DATA: Table 30 Sales of Dermatologicals by Category: Value 2019-2024; Table 31 Sales of Dermatologicals by Category: % Value Growth 2019-2024; Table 32 NBO Company Shares of Dermatologicals: % Value 2020-2024; Table 33 LBN Brand Shares of Dermatologicals: % Value 2021-2024; Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2021-2024; Table 35 Forecast Sales of Dermatologicals by Category: Value 2024-2029; Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2024-2029
NRT SMOKING CESSATION AIDS IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Australia sees fewer daily smokers and higher proportion of those who have never smoked over review period
Vaping law reform takes shape in 2024 as e-cigarette sales become highly regulated
Therapeutic Nicotine Vaping Products (NVPs) to be sold by pharmacies under a doctor or nurse practitioner prescription model
PROSPECTS AND OPPORTUNITIES
Influencer-led campaign aims to counter misinformation that promotes vaping on social media platforms
Smokers in Australia increasingly quit as cost-of-living pressures bite into household budgets
NRT gum and patches to remain most popular formats over forecast period due to convenience factor
CATEGORY INDICATORS: Table 37 Number of Smokers by Gender 2019-2024
CATEGORY DATA: Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2019-2024; Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2019-2024; Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2020-2024; Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2021-2024; Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2024-2029; Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2024-2029
SLEEP AIDS IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Ongoing mental health impact of pandemic and subsequent economic downturn hits home
High number of survey respondents indicate that they suffer sleep problems – but less of a consensus as to sleep solutions
Sleep aids subject to considerable cross-category competition
PROSPECTS AND OPPORTUNITIES
No immediate solution on the horizon for a good night’s sleep
Women’s health in the spotlight as parliamentary inquiry turns attention to menopause
Brands of sleep aids must be mindful of proposed merger
CATEGORY DATA: Table 44 Sales of Sleep Aids: Value 2019-2024; Table 45 Sales of Sleep Aids: % Value Growth 2019-2024; Table 46 NBO Company Shares of Sleep Aids: % Value 2020-2024; Table 47 LBN Brand Shares of Sleep Aids: % Value 2021-2024; Table 48 Forecast Sales of Sleep Aids: Value 2024-2029; Table 49 Forecast Sales of Sleep Aids: % Value Growth 2024-2029
EYE CARE IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Australians concerned about eye health – but also cost of treatment – post-pandemic
Category leader offers broad product mix targeting consumer needs
OTC antihistamine eye drops remain sought-after treatment to counter eye irritation and provide relief for allergy sufferers
PROSPECTS AND OPPORTUNITIES
Increased risk of vision loss and eye health problems as Australian community ages
Rising relationship between eye drops and screen time to the fore
Retailers await decision on proposed merger of Chemist Warehouse and Sigma Healthcare
CATEGORY DATA: Table 50 Sales of Eye Care by Category: Value 2019-2024; Table 51 Sales of Eye Care by Category: % Value Growth 2019-2024; Table 52 NBO Company Shares of Eye Care: % Value 2020-2024; Table 53 LBN Brand Shares of Eye Care: % Value 2021-2024; Table 54 Forecast Sales of Eye Care by Category: Value 2024-2029; Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2024-2029
WOUND CARE IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Australians continue to return to sport, school and work, driving sales of wound care
Band-Aid and Elastoplast dominate sticking plasters/adhesive bandages
Potential presence of industrial “forever chemicals” of concern to Australians
PROSPECTS AND OPPORTUNITIES
Relief promised for those impacted by the hidden epidemic of chronic wounds
Chemist Warehouse/Sigma Healthcare merger could challenge superiority of supermarkets in wound care’s distribution
Stable forecast anticipated, with Chronic Wound Consumables Scheme the only potential obstacle
CATEGORY DATA: Table 56 Sales of Wound Care by Category: Value 2019-2024; Table 57 Sales of Wound Care by Category: % Value Growth 2019-2024; Table 58 NBO Company Shares of Wound Care: % Value 2020-2024; Table 59 LBN Brand Shares of Wound Care: % Value 2021-2024; Table 60 Forecast Sales of Wound Care by Category: Value 2024-2029; Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2024-2029
VITAMINS IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Both single and multivitamins record double-digit volume growth in 2024
Vitamin B leverages anti-stress and anxiety benefits to consumers
Products targeting women’s health and their specific needs a focus area for brands
PROSPECTS AND OPPORTUNITIES
Positive outlook for vitamins as demand for health products expected to remain high
Consumers expected to persist with traditional capsule format for best value
Ageing population creates more opportunities for multivitamin positioning
CATEGORY DATA: Table 62 Sales of Vitamins by Category: Value 2019-2024; Table 63 Sales of Vitamins by Category: % Value Growth 2019-2024; Table 64 Sales of Multivitamins by Positioning: % Value 2019-2024; Table 65 NBO Company Shares of Vitamins: % Value 2020-2024; Table 66 LBN Brand Shares of Vitamins: % Value 2021-2024; Table 67 Forecast Sales of Vitamins by Category: Value 2024-2029; Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2024-2029
DIETARY SUPPLEMENTS IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Dietary supplements records steady performance despite impact of inflation and cost-of-living hikes
Fish oils a key area for dietary supplements in Australia
Herbal/traditional dietary supplements experiences strong growth as consumers learn more about the benefits
PROSPECTS AND OPPORTUNITIES
Steady category performance over the forecast period as inflation eases
Rising levels of stress and anxiety among young people set to increase demand for various dietary supplements
Blackmores likely to retain leadership with expansive product range
CATEGORY DATA: Table 69 Sales of Dietary Supplements by Category: Value 2019-2024; Table 70 Sales of Dietary Supplements by Category: % Value Growth 2019-2024; Table 71 Sales of Dietary Supplements by Positioning: % Value 2019-2024; Table 72 NBO Company Shares of Dietary Supplements: % Value 2020-2024; Table 73 LBN Brand Shares of Dietary Supplements: % Value 2021-2024; Table 74 Forecast Sales of Dietary Supplements by Category: Value 2024-2029; Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2024-2029
WEIGHT MANAGEMENT AND WELLBEING IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Increasing prevalence of obesity linked to demographic factors, as medical professionals strive for a greater understanding of the biology of weight control
GLP-1 prescription medication off-label use constrained due to supply and regulation
Gender-based advertising on social media pays dividends over review period
PROSPECTS AND OPPORTUNITIES
Shifting consumer behaviour, cost-of-living concerns and cross-category competition likely to contribute to falling retail volumes over forecast period
Rebranding linked to lifestyle empowerment and holistic health lines to ensure category’s future relevance
Potential threat from GLP-1 medications per OTC category
CATEGORY DATA: Table 76 Sales of Weight Management and Wellbeing by Category: Value 2019-2024; Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2019-2024; Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2020-2024; Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2021-2024; Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2024-2029; Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2024-2029
SPORTS NUTRITION IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Australians generally enjoy active lifestyles driven by physical health and/or fitness as primary motivation
Cost-of-living concerns lead to more consumers considering alternate sources of protein
Sports supplements in medicinal dosages now regulated as therapeutic goods in Australia
PROSPECTS AND OPPORTUNITIES
Launch of Athena targets gap in market dominated by male-focused brands
Protein water offers interesting expansion opportunities
Potential impact of growth of GLP-1 medications on sports nutrition
CATEGORY DATA: Table 82 Sales of Sports Nutrition by Category: Value 2019-2024; Table 83 Sales of Sports Nutrition by Category: % Value Growth 2019-2024; Table 84 NBO Company Shares of Sports Nutrition: % Value 2020-2024; Table 85 LBN Brand Shares of Sports Nutrition: % Value 2021-2024; Table 86 Forecast Sales of Sports Nutrition by Category: Value 2024-2029; Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2024-2029
HERBAL/TRADITIONAL PRODUCTS IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Consumer demand for “natural” products drives NPD within analgesics
More routine use of herbal ingredients to help consumers tackle mental health and wellbeing
Appeal of herbal products also linked to sustainability and vegan claims
PROSPECTS AND OPPORTUNITIES
Abundance of processed food and supplements in consumer diets helps the “natural” positioning of herbal/traditional products
Demand for weight loss solutions on the rise as obesity concerns grow
Herbal/traditional products expected to face cross-category competition
CATEGORY DATA: Table 88 Sales of Herbal/Traditional Products by Category: Value 2019-2024; Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2019-2024; Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2020-2024; Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2021-2024; Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2024-2029; Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2024-2029
PAEDIATRIC CONSUMER HEALTH IN AUSTRALIA
KEY DATA FINDINGS
2024 DEVELOPMENTS
Paediatric acetaminophen tablets subject to pack size reductions per channel
Taste Bubs helps parents to introduce common allergens to infants to reduce the risk of developing life-threatening food allergies
Subdued birth rates slow sales of nappy (diaper) rash treatments
PROSPECTS AND OPPORTUNITIES
The “world’s allergy capital” likely to feel ramifications of allergic disease and associated conditions over forecast period and beyond
Paediatric medications and related categories targeting children to be subject to continual reviews over forecast period
Proposed Chemist Warehouse/Sigma Healthcare merger could lead to further distribution concentration within pharmacies
CATEGORY DATA: Table 94 Sales of Paediatric Consumer Health by Category: Value 2019-2024; Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2019-2024; Table 96 NBO Company Shares of Paediatric Consumer Health: % Value 2020-2024; Table 97 LBN Brand Shares of Paediatric Consumer Health: % Value 2021-2024; Table 98 Forecast Sales of Paediatric Consumer Health by Category: Value 2024-2029; Table 99 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2024-2029